Prophylactic and Therapeutic Modulation of the OGF-OGFr Axis Ameliorates Angiogenesis-associated Pathology in Experimental Autoimmune Encephalomyelitis
Journal of Experimental Neurology · 2025 · 6 (2) · 67-75
DOI: 10.33696/neurol.6.110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Neurology, 2025. Verfasst von Laura B. Odom und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic autoimmune disease associated with inflammation and neurodegeneration of the central nervous system. MS pathogenesis includes angiogenesis, the formation of new blood vessels from existing vasculature. Angiogenesis facilitates the migration of inflammatory immune cells across the blood-brain barrier in MS. The opioid growth factor (OGF)-opioid growth factor receptor (OGFr) axis is a potential target for limiting angiogenesis in MS. OGF is a ubiquitous endogenous opioid with inhibitory growth properties when bound to OGFr. Low dosages of naltrexone (LDN), an opioid receptor antagonist, transiently block OGFr and lead to upregulated OGF production when naltrexone is unbound. To investigate the role of the OGF-OGFr axis in angiogenesis in a preclinical model of MS, C57BL/6 mice were immunized with myelin oligodendrocyte glycoprotein (MOG35-55) to establish chronic progressive experimental autoimmune encephalomyelitis (EAE). Mice were treated with intraperitoneal OGF (10 mg/kg) or LDN (0.1 mg/kg) prophylactically for 10 days or therapeutically for 10 days or 3 weeks. Prophylactically treated EAE + OGF or EAE + LDN mice had markedly reduced spinal cord inflammation (OGF: p=0.03; LDN: p
Zitieren
APA
Odom, L. B., Zagon, I. S., & McLaughlin, P. J. (2025). Prophylactic and Therapeutic Modulation of the OGF-OGFr Axis Ameliorates Angiogenesis-associated Pathology in Experimental Autoimmune Encephalomyelitis. Journal of Experimental Neurology, 6(2), 67-75. https://doi.org/10.33696/neurol.6.110
Vancouver
Odom LB, Zagon IS, McLaughlin PJ. Prophylactic and Therapeutic Modulation of the OGF-OGFr Axis Ameliorates Angiogenesis-associated Pathology in Experimental Autoimmune Encephalomyelitis. Journal of Experimental Neurology. 2025;6(2):67-75. doi:10.33696/neurol.6.110
BibTeX
@article{Odom2025,
author = {Odom, Laura B. and Zagon, Ian S. and McLaughlin, Patricia J.},
title = {Prophylactic and Therapeutic Modulation of the OGF-OGFr Axis Ameliorates Angiogenesis-associated Pathology in Experimental Autoimmune Encephalomyelitis},
journal = {Journal of Experimental Neurology},
year = {2025},
volume = {6},
number = {2},
pages = {67--75},
doi = {10.33696/neurol.6.110}
}
EUVIMED